Shares of HIVE Blockchain Technologies Ltd. (CVE:HIV – Get Free Report) have earned an average rating of “Strong Buy” from the five ratings firms that are presently covering the company, Marketbeat.com reports. Five research analysts have rated the stock with a strong buy rating.
A number of research firms have recently weighed in on HIV. Roth Capital raised HIVE Blockchain Technologies to a “strong-buy” rating in a research note on Wednesday, December 18th. Keefe, Bruyette & Woods upgraded shares of HIVE Blockchain Technologies to a “moderate buy” rating in a research note on Wednesday, January 8th. Finally, Rosenblatt Securities upgraded shares of HIVE Blockchain Technologies to a “strong-buy” rating in a research note on Friday, March 7th.
Get Our Latest Stock Report on HIV
HIVE Blockchain Technologies Price Performance
HIVE Blockchain Technologies Ltd. is a business services company in the Business Services industry.
See Also
- Five stocks we like better than HIVE Blockchain Technologies
- What Does Downgrade Mean in Investing?
- Archer Aviation’s Africa Deal Could Boost ACHR Stock
- What is diluted earnings per share (Diluted EPS)?
- Are Short Sellers Wrong About These 3 Semiconductor Stocks?
- Why Invest in High-Yield Dividend Stocks?
- Boeing Gets $50B in March Orders—Is BA Stock a Buy Now?
Receive News & Ratings for HIVE Blockchain Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HIVE Blockchain Technologies and related companies with MarketBeat.com's FREE daily email newsletter.
